Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)
      QxMD      Google Scholar   
Citation:
Osteoporos Int vol 26 (7) 1971-1977
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
4
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
   
Pharmas:
 
Grants:
CA35415, CA33601, N01 CA035431, U10 CA035269, CA35103, U10 CA031946, U10 CA033601, U10 CA037404, UG1 CA189823, P30 CA015083, U10 CA035415, CA25224, U10 CA035431, U10 CA025224, CA31946, CA35269, CA37404, U10 CA035103  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-MN026, PR028   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N02C1, NCCTG-N03CC
Phases:
3
Keywords:
Bone mineral density, Breast cancer, Cancer survivorship, Endpoints, Osteoporosis